Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Abstract
We estimated the age‐specific duration of the preclinical, prodromal, and dementia stages of Alzheimer's disease (AD) and the influence of sex, setting, apolipoprotein E (APOE) genotype, and cerebrospinal fluid tau on disease duration.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 01, 2019
- Source ID
- 10.1016/j.jalz.2019.04.001
Entities
People
- Aibl Research Group
- Ardo Van Den Hout
- For The Alzheimer Disease Neuroimaging Initiative
- Frans R.j. Verhey
- Graciela Muniz‐terrera
- Henrik Zetterberg
- Hilkka Soininen
- Ictus/dsa Study Groups
- Ingmar Skoog
- Isabelle Bos
- Kaj Blennow
- Lisa Vermunt
- Luisa Spiru
- Magda Tsolaki
- Marcel Olde Rikkert
- Paul Maruff
- Philip Scheltens
- Pierre‐jean Ousset
- Pieter Jelle Visser
- Ron Handels
- Sietske A.m. Sikkes
- Silke Kern
- Wiesje M. Van Der Flier
- Yvonne Freund‐levi
- Åsa K. Wallin
Organizations
- Alzheimer's Association
- Aristotle University of Thessaloniki
- COGSTATE LTD
- Carol Davila University of Medicine and Pharmacy
- Centre Hospitalier Universitaire Toulouse
- European Commission
- Harvard Medical School
- Interreg
- Karolinska University Hospital
- King's College London
- Lund University
- Maastricht University
- National Institutes of Health
- Radboud University Medical Centre
- Sahlgrenska University Hospital
- Seventh Framework Programme
- Swedish Research Council
- Swedish Research Council for Health Working Life and Welfare
- United States Department of Defense
- University College London
- University Medical Center Utrecht
- University of Eastern Finland
- University of Edinburgh
- Vrije Universiteit Amsterdam